BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.
| Business Model | Commerce |
|---|---|
| CAGE Code | 8FVJ9 |
| Legal Name | BridgeBio Pharma, Inc. |
| Company Operating Status | Active |
| Full Address | 421 Kipling St, Palo Alto, California US |
| Motto/Tagline | Hope Through Rigorous Science |
| Previous Name | BridgeBio Pharma LLC |
| Stock Symbol | BBIO |
| Ticker Symbol | BBIO |
| Wellfound ID | bridgebio |